1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy Brolucizumab 6mg - Macular Polypoidal Choroidal Vasculopathy (PCV) | Phase 3 | Completed | Novartis Pharmaceuticals | 148 | 2023-02-06 | 2025-12-15 |
Eye Diseases (1) · Retinal Diseases (1) · Scotoma (1) · Vascular Diseases (1)
Cardiovascular Diseases (1) · Choroid Diseases (1) · Choroidal Neovascularization (1) · Metaplasia (1) · Neovascularization, Pathologic (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Uveal Diseases (1) · Vision Disorders (1)
brolucizumab (1)
South Korea (1)